Arteaga CL - Search Results

1

Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.

Wang SE, Wu FY, Shin I, Qu S, Arteaga CL. Wang SE, et al. Among authors: arteaga cl. Mol Cell Biol. 2005 Jun;25(11):4703-15. doi: 10.1128/MCB.25.11.4703-4715.2005. Mol Cell Biol. 2005. PMID: 15899872 Free PMC article.

2

Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.

Arteaga CL, Coffey RJ Jr, Dugger TC, McCutchen CM, Moses HL, Lyons RM. Arteaga CL, et al. Cell Growth Differ. 1990 Aug;1(8):367-74. Cell Growth Differ. 1990. PMID: 2177634

3

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT. Arteaga CL, et al. J Clin Invest. 1993 Dec;92(6):2569-76. doi: 10.1172/JCI116871. J Clin Invest. 1993. PMID: 7504687 Free PMC article.

4

Pretreatment with vitamin A inhibits transforming growth factor alpha stimulation of human mammary carcinoma cells.

Halter SA, Winnier AR, Arteaga CL. Halter SA, et al. Among authors: arteaga cl. J Cell Physiol. 1993 Jul;156(1):80-7. doi: 10.1002/jcp.1041560112. J Cell Physiol. 1993. PMID: 7686167

5

p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair.

Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD, Stewart SJ. Arteaga CL, et al. Cancer Res. 1994 Jul 15;54(14):3758-65. Cancer Res. 1994. PMID: 7913407

6

Evidence for a positive role of transforming growth factor-beta in human breast cancer cell tumorigenesis.

Arteaga CL, Dugger TC, Winnier AR, Forbes JT. Arteaga CL, et al. J Cell Biochem Suppl. 1993;17G:187-93. doi: 10.1002/jcb.240531134. J Cell Biochem Suppl. 1993. PMID: 8007696

7

Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.

Arteaga CL, Hurd SD, Dugger TC, Winnier AR, Robertson JB. Arteaga CL, et al. Cancer Res. 1994 Sep 1;54(17):4703-9. Cancer Res. 1994. PMID: 8062268

8

Epidermal growth factor stimulates substrate-selective protein-tyrosine-phosphatase activity.

Hernández-Sotomayor SM, Arteaga CL, Soler C, Carpenter G. Hernández-Sotomayor SM, et al. Among authors: arteaga cl. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7691-5. doi: 10.1073/pnas.90.16.7691. Proc Natl Acad Sci U S A. 1993. PMID: 8102801 Free PMC article.

9

The epidermal growth factor receptor is associated with phospholipase C-gamma 1 in meningiomas.

Johnson MD, Horiba M, Winnier AR, Arteaga CL. Johnson MD, et al. Among authors: arteaga cl. Hum Pathol. 1994 Feb;25(2):146-53. doi: 10.1016/0046-8177(94)90270-4. Hum Pathol. 1994. PMID: 8119714

10

Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.

Arteaga CL, Carty-Dugger T, Moses HL, Hurd SD, Pietenpol JA. Arteaga CL, et al. Cell Growth Differ. 1993 Mar;4(3):193-201. Cell Growth Differ. 1993. PMID: 8466857

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

414 results

Search Page